Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 887-890

  Pearson, A Scott ^a   Spitz, Francis R ^a   Swisher, Stephen G ^b   Kataoka, Masafumi ^b   Sarkiss, Mona G ^a   Meyn, Raymond E ^b   McDonnell, Timothy J ^a   Cristiano, Richard J ^b   Roth, Jack A ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; VIRUS VECTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DNA TRANSFER; GENE THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TREATMENT OUTCOME;

ADENOVIRIDAE; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; DNA, RECOMBINANT; GENE TRANSFER TECHNIQUES; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0034019910     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zhang, W. W., Fang, X., Mazur, W., French, B. A., Georges, R. N., and Roth, J. A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther., 1: 5-13, 1994.
2. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. M. Involvement of the bcl-2 oncogene in human follicular lymphoma. Science (Washington DC), 225: 1440-1443, 1985.
3. Krajewski, S., Krajewska, M., Shabaik, A., Wang, H. G., Irie, S., Fong, L., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res., 54: 5501-5507, 1994.
4. Krajewski, S., Krajewska, M., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of bak expression, a proapoptotic member of the bcl-2 protein family. Cancer Res., 56: 2849-2855, 1996.
5. Sedlak, T. W., Oltvai, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA, 92: 7834-7838, 1995.
6. Chiou, S. K., Rao, L., and White, E. Bcl-2 blocks p53 dependent apoptosis. Mol. Cell. Biol., 14: 2556-2563, 1994.
7. Marin, M. C., Hsu, B., Meyn, R. E., Donehower, L. A., El-Naggar, A. K., and McDonnell, T. J. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene, 9: 3107-3112, 1994.
8. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell, 80: 293-299, 1995.
9. Yin, C. Y., Knudson, C. M., Korsmeyer, S. J., and Vandyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature (Lond.), 385: 637-640, 1997.
10. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral-mediated transfer of the wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
11. Graham, F. L., and Prevec, L. Manipulation of adenovirus vectors. In: E. Murray (ed.), Methods in Molecular Biology: Gene Transfer and Expression Protocols 7, pp. 205-225. Totowa, NJ: Humana Press, Inc., 1991.
12. Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., and Korsmeyer, S. J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (Washington DC), 270: 96-99, 1995.
13. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I., and Guild, B. C. Induction of apoptosis by the Bcl-2 homologue bak. Nature (Lond.), 374: 733-736, 1995.
14. Miyashita, T., Harigai, M., Hanada, M., and Reed, J. C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res., 54: 3131-3135, 1994.
15. L protein content in HT29 cells. Oncogene, 13: 2631-2637, 1996.
16. Spitz, F. R., Nguyen, D., Skibber, J. M., Meyn, R. E., Cristiano, R. J., and Roth, J. A. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin. Cancer Res., 2: 1665-1671, 1996.
17. Nguyen, D. M., Spitz, F. R., Yen, N., Cristiano, R. J., and Roth, J. A. Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. J. Thorac. Cardiovasc. Surg., 112: 1372-1377, 1996.
18. Sakakura, C., Sweeney, E. A., Shirahama, T., Igarashi, Y., Hakomori, S., Nakatani, H., Tsujimoto, H., Imanishi, T., Ohgaki, M., Ohyama, T., Yamazaki, J., Hagiwara, A., Yamaguchi, T., Sawai, K., and Takahashi, T. Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int. J. Cancer, 67: 101-105, 1996.
19. Wagener, C., Bargou, R. C., and Daniel, P. T. Induction of the death-promoting gene bax-a sensitizes cultured breast cancer cells to drug-induced apoptosis. Int. J. Cancer, 67: 138-141, 1996.
20. McCurrach, M. E., Connor, T. M. F., Knudson, C. M., Korsmeyer, S. J., and Lowe, S. W. Bax deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA, 94: 2345-2349, 1997.